Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Adaptive Radiotherapy Software Market Value Growth And Long-Term Outlook
The adaptive radiotherapy software market has experienced substantial growth in recent years. Its expansion is projected from $0.7 billion in 2025 to $0.81 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this expansion has been driven by factors such as the increasing embrace of image-guided radiotherapy, a global rise in cancer cases, progress in radiation oncology software, the demand for enhanced treatment precision, and the proliferation of radiotherapy facilities.
The adaptive radiotherapy software market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. Several factors contribute to this projected growth during the forecast period, including an increasing need for personalized cancer treatment, the incorporation of AI-driven treatment adaptation, a surge in the adoption of cloud-based oncology software, a heightened emphasis on minimizing radiation toxicity, and substantial investments in cutting-edge oncology infrastructure. Key trends expected during this period involve advancements such as adaptive treatment planning, optimization of doses guided by imaging, individualized radiation therapy protocols, automation of workflows in radiation oncology, and the integration of multi-modality imaging.
Get A Free Sample Report With In-Depth Market Insights:
Adaptive Radiotherapy Software Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating count of cancer diagnoses is anticipated to drive the future expansion of the adaptive radiotherapy software market. Cancer cases specifically refer to the total number of individuals identified with cancer within a defined population over a specified timeframe. There is an observed increase in cancer cases among aging populations, as extended lifespans result in a greater accumulation of genetic mutations, consequently heightening the risk of developing the illness. Adaptive radiotherapy software aids cancer treatment by adjusting radiation therapy in real-time, responding to changes in tumor size, shape, and patient anatomy, which enhances precision, maximizes the targeting of tumors, and minimizes harm to healthy tissues. For example, in February 2025, Cancer Australia, an Australia-based government agency, reported 4,641 new pancreatic cancer cases in 2024, with 2,414 affecting males and 2,227 affecting females. Thus, the increasing number of cancer cases is propelling the growth of the adaptive radiotherapy software market.
Adaptive Radiotherapy Software Market Segment Outlook: Which Categories Are Growing Fastest?
The adaptive radiotherapy software market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Prostate Cancer, Head And Neck Cancer, Breast Cancer, Lung Cancer, Other Applications
4) By End User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Treatment Planning Software, Workflow Management Software, Imaging And Visualization Software
2) By Services: Implementation And Integration Services, Maintenance And Consulting Services, Training And Support Services
#Adaptive Radiotherapy Software Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the adaptive radiotherapy software market are prioritizing the development of technological advancements, such as AI-powered, adaptive CT-Linac systems, to enhance the real-time targeting of tumors, improve the accuracy of treatment, and optimize patient outcomes. An AI-powered, adaptive CT-Linac is a radiation therapy system that combines computed tomography (CT) imaging with a linear accelerator (Linac), utilizing artificial intelligence (AI) to adjust and optimize radiation delivery instantly based on alterations in tumor size, shape, and position during the treatment process. For example, in May 2024, Elekta AB, a Sweden-based medication company, introduced Evo, which is engineered for accurate and efficient radiotherapy treatments. This system is designed to provide highly personalized and precise cancer radiation therapy. It features advanced AI-enhanced imaging, allowing clinicians to visualize tumors with exceptional clarity and modify treatments in real time or between sessions. Evo aims to enhance treatment accuracy, mitigate side effects, and elevate patients’ quality of life, while also enabling clinics to integrate innovative technology at a comfortable pace.
Adaptive Radiotherapy Software Market Key Players Shaping Industry Direction
Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.
View The Full Adaptive Radiotherapy Software Market Report:
Adaptive Radiotherapy Software Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the adaptive radiotherapy software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adaptive radiotherapy software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
